GovChime
Notice ID: 3328612db4ad4a608d796e4bdc908baaSpecial Notice

Q301 - Notice of Intent to Sole-Source Veracyte Decipher Testing Services - Cleveland OH VAMC

Active, responses due . Full description on SAM.gov.

Overview

Response deadline
4:00 PM EST
Posted
November 4, 2026
Notice type
Special Notice
Set-aside
No Set aside used
NAICS
334516: Analytical Laboratory Instrument Manufacturing
Agency
Department of Veterans Affairs

Notice details

Office
250-NETWORK CONTRACT OFFICE 10 (36C250)
Place of performance
Ohio, 44106
PSC
Q301: REFERENCE LABORATORY TESTING
Last updated
Nov 4, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
36C25027Q0091
Notice ID
3328612db4ad4a608d796e4bdc908baa

Description

Notice of Intent to Sole-Source Requirement

The Department of Veterans Affairs, Network Contracting Office (NCO) 10, intends to negotiate a sole source contract under Simplified Acquisition Procedures and the authority of FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements.

The associated NAICS code for this is 334516, Size Standard is 1,000 employees. 

Product Service Code (PSC) is Q301.

The sole-source contract will be awarded to:

VERACYTE, INC

UEI: JS7GBP6LCMN6

Description of equipment requirements:

The VA Northeast Ohio Healthcare System (VANEOHS) requires continued access to specialized genomic classifier testing used to assess risk of metastasis or metastatic progression in patients with localized or advanced prostate cancer.  Decipher prostate testing is a powerful diagnostic and prognostic tool that assesses risk of prostate cancer progression within the next five years post detection, biopsy or surgical removal.  The test utilizes a genome-wide transcriptome assay to analyze the expression of 22 genes to generate the Decipher score.  Performed on existing tissue samples obtained during biopsy or surgical removal of the prostate, prior to any radiation or hormone therapy. Indicated in localized, N1, or metastatic disease.  Provides the Decipher score based on genomic characteristics of the tumor, independent of clinical and pathological factors. The score, ranging between 0 and 1, reflects tumor aggressiveness.

It is the Government's belief that only the proposed candidate possesses the required capabilities to successfully meet this requirement. It is the Government's intention to solicit and negotiate with only this source. This notice of intent is not a request for competitive proposals. IAW FAR 5.207 all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.

This is not a solicitation or request for offers. No solicitation package is available. Any response to this notice must show clear and convincing evidence that demonstrates the ability to comply with the requirement and that competition would be advantageous to the Government.

The Government will not pay for information submitted. A determination not to compete based on responses to this notice is solely within the discretion of the Government.

All responses to this intent to sole source must be emailed to Thomas Bellamy: thomas.bellamy@va.gov & Samantha Jarrett: samantha.jarrett@va.gov by 4:00 p.m. EST November 12th, 2026.

Full description on SAM.gov

Award Overview

Contacts

Contracting Officer

Primary Contact

Thomas Bellamy

Secondary Contact

Samantha Jarrett

Documents

No documents available.

Lifecycle

  1. 1
    Version 1Special NoticeCurrent

    Q301 - Notice of Intent to Sole-Source Veracyte Decipher Testing Services - Cleveland OH VAMC

    Notice 3328612db4ad4a608d796e4bdc908baa on SAM.gov

Similar Opportunities

Additional Details

Solicitation Number

36C25027Q0091

Archive Date

Nov 27, 2026

Office Address

DAYTON, OH, 45428